Literature DB >> 8489190

Reconstruction of the lower extremity after grade III distal tibial injuries using combined microsurgical free tissue transfer and bone transport by distraction osteosynthesis.

S A Spiro1, W Oppenheim, W K Boss, A I Schneider, A M Hutter.   

Abstract

Five patients each with grade IIIB or IIIC distal tibial injuries are presented. All patients were treated initially by multiple debridements and external fixation of the tibial fracture. After failure of the primary treatment, each patient underwent microsurgical free muscle transfer and bone transport of the proximal tibia to reconstruct the lower leg. Soft tissue loss ranged from 8 to 20 cm. Segmental tibial loss ranged from 8 to 18 cm. Free flaps used included rectus abdominis, latissimus dorsi, and combined latissimus dorsi-serratus anterior muscles. Bone transport was accomplished by callus distraction after corticotomy. All patients are ambulatory, fully weight bearing, and without pain (range, 17-34 mo). This treatment method has obviated the need for below-the-knee amputation in all of our patients.

Entities:  

Mesh:

Year:  1993        PMID: 8489190     DOI: 10.1097/00000637-199302000-00001

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  4 in total

1.  Ilizarov bone transport for the treatment of chronic osteomyelitis: a rare complication.

Authors:  D R Gateley; S J Irby; D L Martin; R B Simonis
Journal:  J R Soc Med       Date:  1996-06       Impact factor: 5.344

2.  Outcome of microvascular free-tissue transfer in lower extremity fractures.

Authors:  R H Dennis; B L McCampbell
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

3.  [Analysis of the S.O.T.EST series].

Authors:  Y Tropet; P Garbuio
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-02

4.  Compound grafting of residual vascularized fibular head flap to reconstruct contralateral lateral malleolus: A case report.

Authors:  Peiji Wang; Man-Yi Cui; Jiaju Zhao; Jun Lv
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.